Twist Bioscience

Twist Bioscience is a synthetic DNA production for specialty chemical compounds and drug development. At Twist Bioscience Corporation, they work in the service of customers who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals, and data storage, by using our synthetic DNA tools, their customers are developing ways to better lives and improve the sustainability of the planet. They believe that the faster their customers succeed, the better for all of them, and Twist Bioscience is uniquely positioned to help accelerate their efforts.

Their innovative silicon-based DNA Synthesis Platform provides precision at a scale that we believe is otherwise unavailable to their customers. their platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead.

Twist Bioscience was founded in 2013 and is headquartered in San Francisco, California.

Twist Bioscience, established in 2013 and headquartered in United States, North America., specializes in investments across Biotechnology, Life Science, Pharmaceutical, Education, Universities, Biopharma, Genetics, Health Diagnostics, Financial Services, Finance. Their recent investments include Sphere Fluidics, University of Edinburgh, Horizon Discovery, Innovate UK. The highest investment round they participated in was $60.0M. Among their most notable exits are Sphere Fluidics and University of Edinburgh. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.